ZONITOR Trademark

Trademark Overview

On Tuesday, January 4, 2011, a trademark application was filed for ZONITOR with the United States Patent and Trademark Office. The USPTO has given the ZONITOR trademark a serial number of 85209898. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 1, 2014. This trademark is owned by Glaxo Group Limited. The ZONITOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, immune system related diseases and disorders; Vaccines
zonitor

General Information

Serial Number85209898
Word MarkZONITOR
Filing DateTuesday, January 4, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 1, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 7, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, December 1, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 1, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, April 18, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 17, 2014EXTENSION 5 GRANTED
Wednesday, April 9, 2014EXTENSION 5 FILED
Wednesday, April 9, 2014TEAS EXTENSION RECEIVED
Tuesday, October 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2013EXTENSION 4 GRANTED
Monday, September 30, 2013EXTENSION 4 FILED
Monday, September 30, 2013TEAS EXTENSION RECEIVED
Friday, April 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2013EXTENSION 3 GRANTED
Monday, March 25, 2013EXTENSION 3 FILED
Monday, April 15, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 25, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 6, 2012EXTENSION 2 GRANTED
Tuesday, September 4, 2012EXTENSION 2 FILED
Thursday, September 6, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 4, 2012TEAS EXTENSION RECEIVED
Friday, April 6, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 4, 2012EXTENSION 1 GRANTED
Wednesday, April 4, 2012EXTENSION 1 FILED
Wednesday, April 4, 2012TEAS EXTENSION RECEIVED
Tuesday, October 25, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 9, 2011EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, August 16, 2011CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Friday, August 12, 2011ASSIGNED TO PETITION STAFF
Wednesday, August 10, 2011TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, May 26, 2011EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 26, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2011PUBLISHED FOR OPPOSITION
Monday, March 21, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 21, 2011ASSIGNED TO EXAMINER
Friday, January 7, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 7, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

zonitor pharmaceutical treatment substances preparations diseases disorders oncological hepatological vaccines dysfunction